Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
Thymosin Alpha-1 Thymosin Alpha-1 can modulate immune response and control inflammation
Treatment frequency depends on the type of injection, your wellness goals, lab results, and how your body responds
The most commonly reported code is CPT 96372 , which reports a therapeutic, prophylactic, or diagnostic subcutaneous or intramuscular injection